Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 70518-4616

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 70518-4616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (2e5f04a0 3e2d 494f 837b 18570b6a8546 01)

Chemical structure diagram of acamprosate calcium, showing two molecules each with an acetyl group, amide linkage, alkyl chains, sulfonate groups, and a calcium ion (Ca2+).*

FDA Label Image

Mm1 (Acamprosate Calcium 333mg 70518 4616 00)

Packaging label for Acamprosate Calcium delayed-release tablets, 333 mg strength. The box contains 50 tablets. Labeler is RemedyRepack Inc. The label includes storage instructions and manufacturer information as Zydus Pharma USA Inc., Princeton, NJ. The NDC number 70518-4616-00 is displayed.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Acamprosate Calcium delayed-release tablet, 333 mg strength. The package contains 1 tablet per box. The label includes the NDC number 70518-4616-01 and states it is repackaged by RemedyRepack Inc. in Indiana, PA. Additional manufacturer information is provided for Zydus Pharma USA Inc., Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.